EuroPCR 23: EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions

We are joined onsite by Dr Sandeep Arunothayaraj (University Hospitals Sussex NHS Foundation Trust, UK) to discuss the findings from a five-year follow-up of the EBC Two Trial. (NCT01560455)
EBC Two investigated single-stent versus dual-stent techniques in treating large bifurcation lesions. Over 200 patients were enrolled in the trial. The study found that routine culotte did not improve 5-year MACE in non-left main true bifurcations compared to provisional stenting. Side branch disease length did not affect this result. Only 16% of provisional patients required a second stent, resulting in significant savings in cost, radiation, time and potential procedural complications. These findings strongly support using the provisional strategy as the default approach for bifurcation disease.
Interview Questions:
-What is the background of this study?
-What was the study design, patient population and outcome measures?
-What were the key findings presented at EuroPCR?
-How were operator experience and expertise accounted for in the trial?
-Based on these findings which patients would benefit from a provisional T-stent strategy?
-What are the potential implications for clinical practice?
-What are the next steps?
Recorded on-site at EuroPCR 2023, Paris.
Visit Radcliffe Cardiology: www.radcliffecardiology.com/
Visit Radcliffe Vascular: www.radcliffevascular.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: / radcliffecardiology
Follow us on X: x.com/radcliffeCARDIO